There are a number of factors that contribute to anti-PD-1 resistance, which occurs predominantly in immunosuppressive TME, including absence of tumor antigens, insufficient antigen presentation, immunosuppressive molecules, and insufficient T-cell infiltration [34]. The gene discussed is PDCD1; the disease is neoplasm.